Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs.

Nicotine dependence is one of the world's leading causes of preventable death. To discover genetic variants that influence risk for nicotine dependence, we targeted over 300 candidate genes and analyzed 3713 single nucleotide polymorphisms (SNPs) in 1050 cases and 879 controls. The Fagerström test for nicotine dependence (FTND) was used to assess dependence, in which cases were required to have an FTND of 4 or more. The control criterion was strict: control subjects must have smoked at least 100 cigarettes in their lifetimes and had an FTND of 0 during the heaviest period of smoking. After correcting for multiple testing by controlling the false discovery rate, several cholinergic nicotinic receptor genes dominated the top signals. The strongest association was from an SNP representing CHRNB3, the beta3 nicotinic receptor subunit gene (P = 9.4 x 10(-5)). Biologically, the most compelling evidence for a risk variant came from a non-synonymous SNP in the alpha5 nicotinic receptor subunit gene CHRNA5 (P = 6.4 x 10(-4)). This SNP exhibited evidence of a recessive mode of inheritance, resulting in individuals having a 2-fold increase in risk of developing nicotine dependence once exposed to cigarette smoking. Other genes among the top signals were KCNJ6 and GABRA4. This study represents one of the most powerful and extensive studies of nicotine dependence to date and has found novel risk loci that require confirmation by replication studies.

[1]  L. Kozlowski,et al.  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. , 1991, British journal of addiction.

[2]  Larry Wasserman,et al.  Using linkage genome scans to improve power of association in genome scans. , 2006, American journal of human genetics.

[3]  C. Carlson,et al.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. , 2004, American journal of human genetics.

[4]  M. Spitz,et al.  Case-control study of the D2 dopamine receptor gene and smoking status in lung cancer patients. , 1998, Journal of the National Cancer Institute.

[5]  Ming D. Li,et al.  Haplotype analysis indicates an association between the DOPA decarboxylase (DDC) gene and nicotine dependence. , 2005, Human molecular genetics.

[6]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[7]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[8]  Ming D. Li,et al.  Single- and multilocus allelic variants within the GABA(B) receptor subunit 2 (GABAB2) gene are significantly associated with nicotine dependence. , 2005, American journal of human genetics.

[9]  M. Stephens,et al.  Inference of population structure using multilocus genotype data: dominant markers and null alleles , 2007, Molecular ecology notes.

[10]  A. C. Collins,et al.  A polymorphism in the alpha4 nicotinic receptor gene (Chrna4) modulates enhancement of nicotinic receptor function by ethanol. , 2003, Alcoholism, clinical and experimental research.

[11]  C. Warren,et al.  Patterns of global tobacco use in young people and implications for future chronic disease burden in adults , 2006, The Lancet.

[12]  A. C. Collins,et al.  Long sleep and short sleep mice differ in nicotine-stimulated 86Rb+ efflux and alpha4 nicotinic receptor subunit cDNA sequence. , 2001, Pharmacogenetics.

[13]  Ming D. Li,et al.  Significant association of BDNF haplotypes in European‐American male smokers but not in European‐American female or African‐American smokers , 2005, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[14]  D. Comings,et al.  The dopamine D2 receptor (DRD2) gene: a genetic risk factor in smoking. , 1996, Pharmacogenetics.

[15]  Tanja Popovic,et al.  Annual smoking-attributable mortality, years of potential life lost, and productivity losses--United States, 1997-2001. , 2005, MMWR. Morbidity and mortality weekly report.

[16]  K. Stowman.  World health statistics. , 1949, The Milbank Memorial Fund quarterly.

[17]  A. C. Collins,et al.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice. , 2004, Molecular pharmacology.

[18]  E. Bowman,et al.  Dopamine D4 receptors and the risk of cigarette smoking in African-Americans and Caucasians. , 1998, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[19]  R. Harris,et al.  G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action , 1999, Nature Neuroscience.

[20]  J. Mackay,et al.  The Tobacco Atlas , 2002 .

[21]  A. C. Collins,et al.  Modulation of nicotine but not ethanol preference by the mouse Chrna4 A529T polymorphism. , 2005, Behavioral neuroscience.

[22]  J. Idle,et al.  CYP2D6 genotypes in cigarette smokers and non-tobacco users. , 1996, Pharmacogenetics.

[23]  Nancy L Saccone,et al.  Power‐based, phase‐informed selection of single nucleotide polymorphisms for disease association screens , 2006, Genetic epidemiology.

[24]  S. Lewis,et al.  The generic genome browser: a building block for a model organism system database. , 2002, Genome research.

[25]  B. Madras.  Cell biology of addiction , 2006 .

[26]  B. Greenberg,et al.  Interaction between the serotonin transporter gene and neuroticism in cigarette smoking behavior , 2000, Molecular Psychiatry.

[27]  N. Martin,et al.  Defining nicotine dependence for genetic research: evidence from Australian twins , 2004, Psychological Medicine.

[28]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[29]  J. Lindstrom.  Nicotinic acetylcholine receptors of muscles and nerves: comparison of their structures, functional roles, and vulnerability to pathology. , 2003, Annals of the New York Academy of Sciences.

[30]  Ming D. Li,et al.  Ethnic- and gender-specific association of the nicotinic acetylcholine receptor alpha4 subunit gene (CHRNA4) with nicotine dependence. , 2005, Human molecular genetics.

[31]  P. Shields,et al.  Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence , 2000, Molecular Psychiatry.

[32]  A Elofsson,et al.  Prediction of transmembrane alpha-helices in prokaryotic membrane proteins: the dense alignment surface method. , 1997, Protein engineering.

[33]  E. Bowman,et al.  EVIDENCE SUGGESTING THE ROLE OF SPECIFIC GENETIC FACTORS IN CIGARETTE SMOKING , 1998 .

[34]  P. Donnelly,et al.  Inference of population structure using multilocus genotype data. , 2000, Genetics.

[35]  W. Corrigall,et al.  Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area , 1994, Brain Research.

[36]  John D. Storey.  A direct approach to false discovery rates , 2002 .

[37]  Ming D. Li.  The genetics of nicotine dependence , 2006, Current psychiatry reports.

[38]  R. Tyndale,et al.  Nicotine metabolism defect reduces smoking , 1998, Nature.

[39]  John D. Storey,et al.  Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Geoffrey B. Nilsen,et al.  Whole-Genome Patterns of Common DNA Variation in Three Human Populations , 2005, Science.

[41]  J. Idle,et al.  CYP2D6 genotype and smoking behaviour in cigarette smokers. , 1997, Pharmacogenetics.

[42]  Scott F. Saccone,et al.  Novel genes identified in a high-density genome wide association study for nicotine dependence. , 2007, Human molecular genetics.

[43]  D. Lancet,et al.  Why do young women smoke? I. Direct and interactive effects of environment, psychological characteristics and nicotinic cholinergic receptor genes , 2006, Molecular Psychiatry.

[44]  J. Lindstrom.  Nicotinic Acetylcholine Receptors of Muscles and Nerves , 2003 .

[45]  D. Kooy,et al.  The neurobiology of nicotine addiction: bridging the gap from molecules to behaviour , 2004, Nature Reviews Neuroscience.

[46]  Tianhua Niu,et al.  A common haplotype of the nicotine acetylcholine receptor alpha 4 subunit gene is associated with vulnerability to nicotine addiction in men. , 2004, American journal of human genetics.

[47]  A. C. Collins,et al.  A polymorphism in the mouse neuronal alpha4 nicotinic receptor subunit results in an alteration in receptor function. , 2002, Molecular pharmacology.